<div id="readability-page-1"><p>Sunshine Biopharma (SBFM) stock rocketed higher on Monday despite a lack of news from the pharmaceutical and nutritional supplement company. There are no new press releases or filings with the U.S. Securities and Exchange Commission (SEC) that explain why the stock was up today. The company also doesn't have any upcoming events that would act as a catalyst for the SBFM stock rally, as it reported Q1 2026 earnings earlier this month.</p><h3>Claim 55% Off TipRanks</h3><ul><li>Unlock  hedge fund-level data  and  powerful investing tools  for smarter, sharper decisions  </li><li> Discover top-performing stock ideas and upgrade to a portfolio of market leaders with  Smart Investor Picks  </li></ul> <p>One thing that investors will note about Sunshine Biopharma is its low float of 4.9 million shares. The company also saw incredibly heavy trading today, as some 225 million shares changed hands. For comparison, the company's three-month average daily trading volume is about 1.09 million shares. Today's elevated trading activity combined with the company's low float suggests a stock squeeze.</p> <p>Another thing that investors will want to keep in mind about Sunshine Biopharma is its turbulent history. The company has conducted several stock reverse splits throughout its history to boost the price of its shares and avoid delisting. This is a red flag for investors who are considering a stake in the company.</p> <h2><strong>Sunshine Biopharma Stock Movement Today</strong></h2> <p>Sunshine Biopharma stock was up 561.74% in premarket trading on Monday, following a 39.46% fall on Friday. The shares have dropped 76.9% year-to-date and 80.93% over the past 12 months.</p></div>

SBFM

SBFMW

SBIO

LABU

<p>Sunshine Biopharma (SBFM) stock surged 561.74% in premarket trading despite no new news or events. The company has a low float of 4.9 million shares and experienced heavy trading with 225 million shares exchanged, indicating a potential stock squeeze. However, SBFM has a history of stock reverse splits, raising concerns for investors. Year-to-date, the stock has fallen 76.9% and 80.93% over the past year.</p>

Why Is Penny Stock Sunshine Biopharma (SBFM) Up Today?